Hancock Whitney Corp Abb Vie Inc. Transaction History

Hancock Whitney Corp

$5.37 Billion
Q3 2025

A detailed history of Hancock Whitney Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Hancock Whitney Corp holds 262,585 shares of ABBV stock, worth $61.4 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares

262,585

Previous 266,199 1.36%

Holding current value

$61.4 Million

Previous $49.4 Million 23.05%

% of portfolio

1.13%

Previous 0.97%

37 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 17, 2025	SELL	$184.85 - $231.54 $668,047 - $836,785	-3,614 Reduced 1.36%	262,585 $60.8 Million
Q2 2025 Aug 14, 2025	BUY	$170.16 - $206.27 $36.9 Million - $44.7 Million	216,849 Added 439.41%	266,199 $49.4 Million
Q1 2025 May 15, 2025	SELL	$169.2 - $216.66 $134,175 - $171,811	-793 Reduced 1.58%	49,350 $10.3 Million
Q4 2024 Feb 14, 2025	SELL	$164.99 - $203.87 $969,151 - $1.2 Million	-5,874 Reduced 10.49%	50,143 $8.91 Million
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $296,222 - $360,388	-1,808 Reduced 3.13%	56,017 $11.1 Million

Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $315,926 - $368,931	-2,041 Reduced 3.41%	57,825 $9.92 Million
Q1 2024 May 16, 2024	SELL	$159.82 - $182.1 $481,697 - $548,849	-3,014 Reduced 4.79%	59,866 $10.9 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $9.32 Million - $10.5 Million	-67,737 Reduced 51.86%	62,880 $9.74 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $202,923 - $234,913	-1,519 Reduced 1.15%	130,617 $19.5 Million
Q2 2023 Nov 13, 2023	SELL	$132.51 - $164.9 $785,254 - $977,197	-5,926 Reduced 4.29%	132,136 $17.8 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $785,254 - $977,197	-5,926 Reduced 4.29%	132,136 $17.8 Million
Q1 2023 Nov 13, 2023	SELL	$144.61 - $166.54 $1.6 Million - $1.85 Million	-11,096 Reduced 7.44%	138,062 $22 Million
Q1 2023 May 16, 2023	SELL	$144.61 - $166.54 $1.6 Million - $1.85 Million	-11,096 Reduced 7.44%	138,062 $22 Million
Q4 2022 Nov 13, 2023	BUY	$138.31 - $165.87 $2.35 Million - $2.82 Million	17,022 Added 12.88%	149,158 $24.1 Million
Q4 2022 Feb 03, 2023	BUY	$138.31 - $165.87 $65,835 - $78,954	476 Added 0.32%	149,158 $24.1 Million
Q3 2022 Oct 26, 2022	SELL	$134.21 - $153.93 $746,744 - $856,466	-5,564 Reduced 3.61%	148,682 $20 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $76,103 - $96,752	553 Added 0.36%	154,246 $23.6 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $3.64 Million - $4.52 Million	27,596 Added 21.88%	153,693 $24.9 Million
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $120,966 - $153,057	1,126 Added 0.9%	126,097 $17.1 Million
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $994,201 - $1.13 Million	-9,344 Reduced 6.96%	124,971 $13.5 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $764,350 - $851,530	-7,265 Reduced 5.13%	134,315 $15.1 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $713,031 - $784,961	-6,970 Reduced 4.69%	141,580 $15.3 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $84,192 - $113,668	1,046 Added 0.71%	148,550 $15.9 Million
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $464,687 - $545,389	-5,409 Reduced 3.54%	147,504 $12.9 Million
Q2 2020 Jul 30, 2020	BUY	$73.37 - $98.18 $3.97 Million - $5.31 Million	54,113 Added 54.77%	152,913 $15 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $751,425 - $1.14 Million	11,650 Added 13.37%	98,800 $7.53 Million
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $473,821 - $592,852	6,569 Added 8.15%	87,150 $7.72 Million
Q3 2019 Oct 29, 2019	SELL	$62.98 - $75.72 $6 Million - $7.21 Million	-95,232 Reduced 54.17%	80,581 $6.1 Million
Q2 2019 Aug 29, 2019	BUY	$65.7 - $83.98 $246,637 - $315,260	3,754 Added 2.18%	175,813 $12.8 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $1.49 Million - $1.75 Million	19,253 Added 12.6%	172,059 $13.9 Million
Q4 2018 Feb 15, 2019	SELL	$77.85 - $96.01 $9.04 Million - $11.2 Million	-116,180 Reduced 43.19%	152,806 $14.1 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $11.6 Million - $12.9 Million	130,704 Added 94.52%	268,986 $25.4 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $381,295 - $451,158	-4,247 Reduced 2.98%	138,282 $12.8 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $1.48 Million - $1.98 Million	-16,039 Reduced 10.11%	142,529 $13.5 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $2.92 Million - $3.21 Million	-32,654 Reduced 17.08%	158,568 $15.3 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $1.24 Million - $1.59 Million	-17,815 Reduced 8.52%	191,222 $17 Million
Q2 2017 Aug 11, 2017	BUY	N/A	209,037	209,037 $15.2 Million

Others Institutions Holding ABBV

# of Institutions

4,489

Shares Held

1.28B

Call Options Held

16.9M

Put Options Held

15.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $414B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.

Account

Hancock Whitney Corp Abb Vie Inc. Transaction History